Viz HCM vs PMcardio

PMcardio offers a mobile app and web platform, making it accessible for individual clinicians at the point of care, and also supports enterprise integrations. Viz HCM is cloud-based and integrates into hospital IT systems, but PMcardio's freemium model and mobile-first approach likely offer broader immediate usability for a wider range of users, including those in primary care or emergency settings without full hospital system integration. PMcardio also provides visual AI explainability with heatmaps (ECGxplainu2122), which can enhance user understanding and trust in the AI's interpretations.

PMcardio detects over 50 cardiac conditions, including STEMI/OMI, reduced LVEF, and various arrhythmias, and has been validated in more than 25 studies. Viz HCM focuses specifically on Hypertrophic Cardiomyopathy (HCM) detection and care coordination, with FDA clearance and multiple supporting studies. While Viz HCM is FDA-cleared for its specific use case, PMcardio's broader diagnostic capabilities across numerous cardiac conditions offer wider clinical applicability and value for diverse healthcare professionals.

PMcardio offers a freemium model with 5 free ECG analyses per month and a Pro Plan for unlimited use, providing transparent pricing for individuals and teams. Viz HCM is subscription-based for hospitals and health systems, with CMS reimbursement available for specific CPT codes, but requires contacting the vendor for enterprise pricing. PMcardio's transparent freemium and individual pricing plans offer greater accessibility and value for a broader range of users, especially individual clinicians or smaller practices.

Viz HCM is designed as a cloud-based platform integrated into hospital IT systems (EHR, PACS) and has established CMS reimbursement pathways for its AI-enabled ECG analysis. It also has a BAA and is HIPAA compliant, indicating its suitability for large-scale healthcare deployments. PMcardio also offers enterprise integrations with EHR/CVIS and EMS systems and is HIPAA compliant, but Viz HCM's FDA clearance and established reimbursement framework in the US suggest a more mature enterprise readiness for the US market.

Both tools demonstrate significant innovation in AI-powered ECG analysis. Viz HCM is the first and only FDA-cleared AI algorithm for HCM detection, creating a new regulatory category. PMcardio offers AI explainability with heatmaps (ECGxplainu2122) and detects over 50 cardiac conditions, including subtle occlusion MI patterns, which can be missed by traditional methods. Both are pushing the boundaries of AI in cardiology, making it difficult to definitively pick one over the other in terms of innovation.

PMcardio provides a comprehensive 'Resources' section on its website, including a blog, regulatory information, security details, a help center, and FAQs, along with publications and clinical research. Viz HCM's information primarily focuses on clinical studies and news releases, with a knowledge base overview. While both offer support, PMcardio's publicly available and detailed documentation suggests a more robust and transparent approach to user support and resources.